Dimed S.A. Distribuidora de Medicamentos (BVMF: PNVL3)
10.01
-0.04 (-0.40%)
Sep 11, 2024, 4:46 PM GMT-3
PNVL3 Income Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 4,712 | 4,461 | 3,990 | 3,225 | 2,819 | 2,725 | Upgrade
|
Revenue Growth (YoY) | 11.88% | 11.79% | 23.72% | 14.41% | 3.47% | 12.02% | Upgrade
|
Cost of Revenue | 3,230 | 3,079 | 2,745 | 2,231 | 1,988 | 1,908 | Upgrade
|
Gross Profit | 1,482 | 1,382 | 1,245 | 994.64 | 831.01 | 816.65 | Upgrade
|
Selling, General & Admin | 1,306 | 1,210 | 1,099 | 907.41 | 726.33 | 687.29 | Upgrade
|
Other Operating Expenses | 16.15 | 9.53 | 8 | -15.56 | 11.29 | 10.5 | Upgrade
|
Operating Expenses | 1,322 | 1,220 | 1,107 | 891.85 | 737.62 | 697.79 | Upgrade
|
Operating Income | 159.93 | 161.89 | 137.84 | 102.78 | 93.39 | 118.86 | Upgrade
|
Interest Expense | -105.77 | -102.57 | -70.03 | -37.12 | -35.31 | -34.98 | Upgrade
|
Interest & Investment Income | 37.5 | 34.39 | 18.18 | 16.63 | 6.05 | 2.91 | Upgrade
|
Other Non Operating Income (Expenses) | -8.21 | -6.81 | -7.01 | 2.2 | -9.6 | -6.78 | Upgrade
|
EBT Excluding Unusual Items | 83.45 | 86.9 | 78.99 | 84.49 | 54.54 | 80.02 | Upgrade
|
Gain (Loss) on Sale of Assets | -4.73 | -2.26 | -2.07 | -2.74 | -1.85 | - | Upgrade
|
Other Unusual Items | 6.9 | 6.95 | 1.51 | 1.49 | 0.62 | 0.82 | Upgrade
|
Pretax Income | 85.61 | 91.58 | 78.43 | 83.24 | 53.3 | 80.84 | Upgrade
|
Income Tax Expense | -5.73 | -1.32 | -7.92 | 3.81 | -2.85 | 4.09 | Upgrade
|
Net Income | 91.34 | 92.91 | 86.35 | 79.43 | 56.15 | 76.76 | Upgrade
|
Net Income to Common | 91.34 | 92.91 | 86.35 | 79.43 | 56.15 | 76.76 | Upgrade
|
Net Income Growth | 10.55% | 7.60% | 8.71% | 41.45% | -26.84% | 2.36% | Upgrade
|
Shares Outstanding (Basic) | 149 | 149 | 149 | 150 | 151 | 135 | Upgrade
|
Shares Outstanding (Diluted) | 149 | 149 | 149 | 150 | 152 | 135 | Upgrade
|
Shares Change (YoY) | -0.79% | 0.09% | -0.68% | -1.27% | 11.84% | -0.55% | Upgrade
|
EPS (Basic) | 0.61 | 0.62 | 0.58 | 0.53 | 0.37 | 0.57 | Upgrade
|
EPS (Diluted) | 0.61 | 0.62 | 0.58 | 0.53 | 0.37 | 0.57 | Upgrade
|
EPS Growth | 10.85% | 6.90% | 9.43% | 43.02% | -34.59% | 2.93% | Upgrade
|
Free Cash Flow | 219.99 | 182.2 | 56.18 | 21.13 | 67.1 | 89.27 | Upgrade
|
Free Cash Flow Per Share | 1.48 | 1.23 | 0.38 | 0.14 | 0.44 | 0.66 | Upgrade
|
Dividend Per Share | 0.198 | 0.252 | - | 0.175 | 0.136 | 0.168 | Upgrade
|
Dividend Growth | - | - | - | 28.37% | -19.11% | 15.29% | Upgrade
|
Gross Margin | 31.45% | 30.97% | 31.20% | 30.84% | 29.48% | 29.97% | Upgrade
|
Operating Margin | 3.39% | 3.63% | 3.45% | 3.19% | 3.31% | 4.36% | Upgrade
|
Profit Margin | 1.94% | 2.08% | 2.16% | 2.46% | 1.99% | 2.82% | Upgrade
|
Free Cash Flow Margin | 4.67% | 4.08% | 1.41% | 0.66% | 2.38% | 3.28% | Upgrade
|
EBITDA | 139.29 | 212.49 | 322.41 | 260.56 | 211.17 | 214.2 | Upgrade
|
EBITDA Margin | 2.96% | 4.76% | 8.08% | 8.08% | 7.49% | 7.86% | Upgrade
|
D&A For EBITDA | -20.64 | 50.61 | 184.57 | 157.77 | 117.78 | 95.34 | Upgrade
|
EBIT | 159.93 | 161.89 | 137.84 | 102.78 | 93.39 | 118.86 | Upgrade
|
EBIT Margin | 3.39% | 3.63% | 3.45% | 3.19% | 3.31% | 4.36% | Upgrade
|
Effective Tax Rate | - | - | - | 4.58% | - | 5.05% | Upgrade
|
Revenue as Reported | 4,712 | 4,461 | 3,990 | 3,225 | - | - | Upgrade
|
Advertising Expenses | - | 29.34 | 26.21 | 19.88 | 17.54 | 19.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.